Tevogen Inc. regained compliance with Nasdaq’s $15 million minimum Market Value of publicly held shares requirement for continued listing on The Nasdaq Global Market. That status matters to investors because it addresses the stated continued-listing requirement and leaves the Nasdaq matter closed for the company.

Key Highlights

  • Nasdaq sent Tevogen written notice of restored compliance on September 9, 2026.
  • Chief Executive Officer Ryan Saadi signed the company’s report on September 10, 2026.
  • Tevogen regained compliance with the stated requirement under the exchange’s continued-listing standards.

Nasdaq Notice Confirms Compliance Nasdaq

The threshold is part of the exchange’s continued-listing standards. sent Tevogen (NASDAQ: TVGN) written notice of the status on September 9, 2026. Ryan Saadi, the company’s chief executive officer, signed the report on September 10, 2026.

Listing Matter Is Now Closed Nasdaq

closed the matter after Tevogen regained compliance with the stated requirement. Tevogen’s update therefore records a completed compliance status under the specific Nasdaq rule cited in the notice.